D-galactose (Orpha Labs)

N/A

Report date: 2024/11/20 20:00:31
NME

Base Information

Drug NameD-galactose (Orpha Labs)
Drug Alias NameORL-1G
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsGlycogen Storage Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTurkey
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOrpha Labs
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrpha Labs
Active IndicationsN/A
Inactive IndicationsGlycogen Storage Disease

Other Information

ATC CodeN/A
Related LinksN/A